Adoptive T cell therapy: An overview of obstacles and opportunities-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adoptive T cell therapy: An overview of obstacles and opportunities

Published:2017-05-19 Issue:S11 Volume:123 Page:2154-2162
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Baruch Erez Nissim¹²,Berg Amy Lauren¹,Besser Michal Judith¹²,Schachter Jacob¹²,Markel Gal¹²³

Affiliation:

1. The Ella Lemelbaum Institute of Immuno-oncology, Institute of Oncology; Sheba Medical Center; Tel Hashomer Israel

2. Sackler Faculty of Medicine; Tel Aviv University; Tel Aviv Israel

3. Talpiot Medical Leadership Program; Sheba Medical Center; Tel Hashomer Israel

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference93 articles.

1. Nivolumab and ipilimumab versus ipilimumab in untreated melanoma;Postow;N Engl J Med.,2015

2. Association of pembrolizumab with tumor response and survival among patients with advanced melanoma;Ribas;JAMA.,2016

3. Pooled analysis of long-term survival data from phase II and phase III trials of ipilimumab in unresectable or metastatic melanoma;Schadendorf;J Clin Oncol.,2015

4. Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report;Rosenberg;N Engl J Med.,1988

5. Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients;Besser;Clin Cancer Res.,2010

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research advances of nanoparticles for CAR-T therapy in solid tumors;Chinese Chemical Letters;2023-12

2. Advances in adoptive T-cell therapy for metastatic melanoma;Current Research in Translational Medicine;2023-07

3. Non-Hodgkin Lymphoma – Nodal and Extranodal: 20-Year Comparative Mortality, Survival & Biologic Behavior Analysis by Age, Sex, Race, Stage, Cell Morphology/Histology, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 384,651 Total NHL Cases Including 261,144 Nodal and 123,507 Extranodal Cases for Diagnosis Years 1975-2016: (SEER*Stat 8.3.6);Journal of Insurance Medicine;2023-07-01

4. Adjuvant Therapy with Oncolytic Adenovirus Delta-24-RGDOX After Intratumoral Adoptive T-cell Therapy Promotes Antigen Spread to Sustain Systemic Antitumor Immunity;Cancer Research Communications;2023-06-27

5. Nanomaterials-involved strategies for reversing the immunosuppressive factors and improving antitumor immunotherapy;Nano Today;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3